External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

AAMDSIF 2023

October 26 - October 27

Rockville, USA

default.salsalabs.org

Add to calendar

Medical Materials

Agenda

Coming soon

10:00 PM

Duration 10mins Rockville, USA

THE PHASE III RANDOMIZED, MULTICENTER COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

Phillip Scheinberg, Diego Villa Clé, John Edwards, Valentina Giai, Marek Hus, Jin Seok Kim, Cristina Barrenetxea Lekue, Zsolt Nagy, Erfan Nur, Jens Panse, Yasutaka Ueda, Mustafa N. Yenerel, Anita Appius, Nadiesh Balachandran, Sammy Chebon, Brittany Gentile, Simon Buatois, Austin G Kulasekararaj

Haematology | Paroxysmal Nocturnal Hemoglobinuria

Add to calendar

Duration 10mins Rockville, USA

THE PHASE III, RANDOMIZED, MULTICENTER COMMODORE 2 TRIAL: RESULTS FROM THE STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS

Alexander Röth, Guangsheng He, Andres Brodsky, Chatree Chai-Adisaksopha, Teresita E. Dumagay, Roberta Demichelis Gómez, Martin Höglund, Richard J. Kelly, Je-Hwan Lee, Jun-ichi Nishimura, Naoshi Obara, Antonio Risitano, Anna Gaya, Anita Appius, Brittany Gentile, Raluca Negricea, Zilu Zhang, Simon Buatois, Bing Han

Haematology | Paroxysmal Nocturnal Hemoglobinuria

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.